The Evolving Role of Bone Marrow Transplant in the Cure of Blood Disorders and Cancers - Dr Suparno Chakrabarti

Bone marrow transplants, more accurately known as Blood Or Marrow Stem Cell Transplant (BMT), is one of the most significant advancements in the treatment of serious blood disorders, and certain cancers as well. In simple words, it is a procedure in which diseased Bone Marrow is replaced by healthy stem cells, which allow the body to rebuild the production of healthy blood cells.

It is primarily used in selected patients with blood cancers such as leukemia, lymphoma, and multiple myeloma, and also in some non-cancerous blood disorders including thalassemia, aplastic anemia, certain autoimmune diseases and inherited diseases.

What can a BMT achieve?

The bone marrow is the soft tissue inside the bones where blood cells are produced. When this system is severely impacted by cancer, failure of bone marrow production, or high dose cancer treatment, a transplant can help to restore the production of normal red blood cells, white blood cells, and platelets as well.

Transplantation is not just a rescue treatment after high dose chemotherapy or radiation to eliminate the cancer cells, but it is about the anti-cancer immune system that generates from the donors’ stem cells which help in eliminating the residual cancer cells.

Conditions Where BMT can be curative.

BMT is most commonly linked with blood cancers like leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, and related disorders. Beyond blood cancer, it can also be used for many blood diseases such as aplastic anemia, thalassemia, sickle cell disease and Fanconi Anemia. In all these inherited disorders, transplant usually offers the possibility of long-term control of diseases, and for many patients, a potential cure as well.

Types of BMT

There are broadly two types of BMT. In an Autologous BMT, own stem cells of patients are collected, stored and returned after the high dose treatments. This kind of approach is often used in some blood cancers and autoimmune diseases since it helps the bone marrow to recover after the intensive therapy and re-educates the immune system.

The other type, Allogenic BMT, can be from a matched related/ matched unrelated or a haploidentical (half-matched) family donor. This type of BMT can be powerful, because in addition to restoring marrow function, donor immune cells may also help to attack the remaining cells of cancers.

Why BMT Can Be Life-Saving

The main value of BMT lies in its potential to offer certain outcomes that regular treatment cannot achieve alone. For some patients with aggressive blood cancers, it also provides the best chance of long-term remission.

For others with the failure of bone marrow or inherited blood disorders, it can even replace a failing blood-forming system with a healthy one. In those children with sickle cell disease or thalassemia who have a matched related donor, blood and bone marrow transplant has successful outcomes with potential cures in over 90% of patients. Even if matched donor is not available, when done at the right centre with the right expertise, a haploidentical (half-matched) family donor BMT is also a possibility.

Risks and Challenges

Despite all these benefits, BMT is a very complex treatment which usually requires careful selection of patients and donors, well specialized centres, and close level of monitoring as well. Possible complications mainly include, toxicity to organs, severe infections, graft failure, and in allogenic BMT, where donor immune cells can attack the tissue of recipients.

Recovery can take weeks to months, and journey of treatment involves prolonged hospitalization, good supportive care, and long term follow up as well. This is the reason why decisions to proceed with transplant is always individualized, balancing potential benefits against the risks.

The Way Forward

In today’s time, BMT continues to remain as the cornerstone of advanced haematology and oncology. With the advancements in science, personalized precision treatments with careful patient and donor selection, cellular therapies and holistic approach would be the way forward to maximize the benefits of this complex yet highly effective therapy.

Disclaimer: The views expressed in this article are of the author and not of Health Dialogues. The Editorial/Content team of Health Dialogues has not contributed to the writing/editing/packaging of this article.